Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Schizophrenia
New Hope for Schizophrenia Patients
July 22nd, 2007
In a keynote presentation at Life Sciences 2007 (a meeting of the Biochemical Society, the British Pharmacological Society and The Physiological Society in SECC Glasgow 8th-12th July) Glasgow-based life sciences company, Scottish Biomedical, will be disclosing for the first time its discovery of potential new treatments for mental diseases such as schizophrenia. Scottish Biomedical has applied its acknowledged world-class experience in cellular signalling mechanisms to link the function of the enzyme phosphodiesterase-11 (PDE11) to schizophrenia. PDEs play and essential role in controlling cellular messages and as a result, specific PDE inhibitors have been identified...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
